sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
5-Mar-2015 19:12
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 201-225 out of 960.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
ASMQ FDC proves safe and efficacious to treat children in Africa with malaria
Presented today at the 63rd annual meeting of the American Society of Tropical Medicine and Hygiene, results of a multi-centre clinical trial in Africa, launched in 2008, to test the efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination in children under 5 years of age with uncomplicated falciparum malaria showed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine FDC -- Africa's most widely adopted treatment.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 4-Nov-2014
mBio
Ebola, Marburg viruses edit genetic material during infection
Filoviruses like Ebola 'edit' genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology. The work, by researchers at the Icahn School of Medicine at Mount Sinai, the Galveston National Laboratory, and the J. Craig Venter Institute, could lead to a better understanding of these viruses, paving the way for new treatments down the road.
National Institutes of Health, J. Craig Venter Institute

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology

Public Release: 4-Nov-2014
PLOS Medicine
Preventing postpartum hemorrhage
Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to trial results published in PLOS Medicine. The randomized non-inferiority trial, conducted by Esther Cathyln Atukunda at the Mbarara University of Science and Technology, Uganda, and colleagues, showed that PPH incidence in the misoprostol arm exceeded that in the oxytocin arm by 11.2 percent.
Father Bash Foundation, Divine Mercy Hospital

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
American Journal of Tropical Medicine and Hygiene
New research: Undiagnosed, undertreated Chagas disease emerging as US public health threat
Across a broad swath of the southern United States, residents face a tangible but mostly unrecognized risk of contracting Chagas disease -- a stealthy parasitic infection that can lead to severe heart disease and death -- according to new research presented today at the American Society of Tropical Medicine and Hygiene Annual Meeting.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
New study: Forensic DNA test conclusively links snake bite marks on people to species
Starting with a simple DNA swab taken from fang marks on people bitten by snakes, an international research team correctly identified the species of the biting snake 100 percent of the time in a first-of-its-kind clinical study, according to data presented today at the American Society of Tropical Medicine and Hygiene's (ASTMH) Annual Meeting.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 3-Nov-2014
AAPS Annual Meeting and Exposition
Nasal spray vaccine has potential for long-lasting protection from Ebola virus
A nasal vaccine in development by researchers at the University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus.

Contact: Amanda Johnson
ajohnson@spectrumscience.com
202-587-2520
American Association of Pharmaceutical Scientists

Public Release: 3-Nov-2014
ASTMH 63rd Annual Meeting
Malaria from monkeys now dominant cause of human malaria hospitalizations in Malaysia
The majority of malaria hospitalizations in Malaysia are now caused by a dangerous and potentially deadly monkey-borne parasite once rarely seen in humans, and deforestation is the potential culprit in a growing number of infections that could allow this virulent malaria strain to jump from macaque monkeys to human hosts, according to research presented today at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New malaria vaccines to prevent infection and block transmission get a shot in the arm
In support of a bold quest to rid the world entirely of malaria, the Bill & Melinda Gates Foundation today announced an award of US$156 million to PATH to support the PATH Malaria Vaccine Initiative in building new vaccines that will interrupt the cycle of malaria parasite transmission and help realize the 'accelerating to zero' agenda. Such vaccines would ensure that parasite reintroduction is prevented by providing what could be called an 'immunological bed net.'
Bill & Melinda Gates Foundation

Contact: Kelsey Mertes
kmertes@path.org
301-312-7844
PATH Malaria Vaccine Initiative (MVI)

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New test will combat major cause of preventable blindness in Africa
PATH, an international nonprofit organization, announces the availability of a point-of care diagnostic tool for Onchocerciasis, commonly known as river blindness. It is the first in a suite of diagnostic innovations by PATH intended to support the elimination of neglected tropical diseases, a group of illnesses that affect more than a billion people worldwide.
The Bill & Melinda Gates Foundation

Contact: Kate Davidson
kdavidson@path.org
206-302-4637
PATH

Public Release: 31-Oct-2014
PLOS ONE
New step towards eradication of H5N1 bird flu
A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or 'bird flu' with those that have been naturally infected.

Contact: Dr. Farhid Hemmatzadeh
farhid.hemmatzadeh@adelaide.edu.au
61-041-074-9766
University of Adelaide

Public Release: 30-Oct-2014
Technology and Innovation
Patents for humanity: Special edition of Technology and Innovation
The current special issue of Technology and Innovation is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. It includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs.

Contact: Diana Vergara
vergara@usf.edu
813-974-1347
University of South Florida (USF Innovation)

Public Release: 30-Oct-2014
Science
Hygienic funerals, better protection for health workers offer best chance to stop Ebola
Hygienic funeral practices, case isolation, contact tracing with quarantines, and better protection for health care workers are the keys to stopping the Ebola epidemic that continues to expand in West Africa, researchers said today in a new report in the journal Science. They said broad implementation of aggressive measures they recommend could lead to its control in Liberia, the focal point, by mid-March.
National Institutes of Health

Contact: Jan Medlock
jan.medlock@oregonstate.edu
541-737-6874
Oregon State University

Public Release: 30-Oct-2014
Science
Genetic factors behind surviving or dying from Ebola shown in mouse study
A newly developed mouse model suggests that genetic factors are behind the mild-to-deadly range of responses to the Ebola virus. The frequency of different manifestations of the disease across the lines of these mice are similar in variety and proportion to the spectrum of clinical disease observed in the 2014 West African outbreak. The new mouse model might be useful in testing candidate therapeutics and vaccines for Ebola, and in finding genetic markers for susceptibility and resistance to the disease.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases, Office of NIH Director

Contact: Leila Gray
leilag@uw.edu
206-685-0381
University of Washington Health Sciences/UW Medicine

Public Release: 29-Oct-2014
Global Health Action
Largest ever dataset of individual deaths in Africa & SE Asia reveals changing health
An unprecedented insight into the changing health of people across Africa and Asia -- including the fluctuating burdens of HIV, malaria and childhood mortality -- is revealed today by the publication of the largest ever dataset of individual deaths recorded on-the-ground.
Bill & Melinda Gates Foundation, Doris Duke Charitable Foundation, IDRC, Rockefeller Foundation, Sida/Research Cooperation Unit, WHO/HMN, William & Flora Hewlett Foundation, Wellcome Trust

Contact: Clare Ryan
c.ryan@wellcome.ac.uk
44-020-761-17262
Wellcome Trust

Public Release: 29-Oct-2014
Global Public Health
NYU research: Tourism as a driver of illicit drug use, HIV risk in the DR
The study's results suggest three themes: 1, local demand shifts drug routes to tourism areas, 2, drugs shape local economies and 3, drug use facilitates HIV risk behaviors in tourism areas.
New York University/Global Public Health Research Challenge Fund

Contact: christopher james
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 29-Oct-2014
PLOS ONE
Maasai of Tanzania facing severe food insecurity and chronic child malnourishment
In the first in-depth study of its kind of the Maasai people of Tanzania, research led by the London School of Hygiene & Tropical Medicine has revealed that the health of Maasai children is very poor compared to other ethnic groups.
UK Medical Research Council

Contact: Jenny Orton
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 28-Oct-2014
Proceedings of the National Academy of Sciences
UC Davis scientists discover exact receptor for DEET that repels mosquitoes
The odorant receptor that makes DEET repellant to mosquitoes has been identified by a research team led by the University of California, Davis.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Pat Bailey
pjbailey@ucdavis.edu
530-752-9843
University of California - Davis

Public Release: 28-Oct-2014
ACP expresses concern about mandatory quarantines of clinicians involved
The American College of Physicians is strongly concerned about the approach being taken by some state health departments to impose strict, mandatory quarantines for all physicians, nurses, and other health professionals returning from West Africa, regardless of whether they are showing symptoms of Ebola virus infection.

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians

Public Release: 28-Oct-2014
PIDS supports IDSA statement on involuntary quarantine of healthcare workers returning from Ebola-affected countries
The Pediatric Infectious Diseases Society endorses a statement from the Infectious Diseases Society of America regarding involuntary quarantine of healthcare workers returning from Ebola-affected countries.

Contact: Terri Christene Phillips
cphillips@idsociety.org
703-299-9865
Pediatric Infectious Diseases Society

Public Release: 28-Oct-2014
American Journal of Roentgenology
Lessons learned from SARS pandemic should inform current contagion protocols
Radiologists in Singapore outline the ways in which both medical facilities and practitioners there have incorporated lessons learned from the SARS pandemic.

Contact: Lissa D. Hurwitz
lhurwitz@arrs.org
703-858-4332
American Roentgen Ray Society

Public Release: 28-Oct-2014
11th International Conference of the Society for Integrative Oncology
UTHealth research shows mushroom extract, AHCC, helpful in treating HPV
A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus, according to a pilot clinical trial at The University of Texas Health Science Center at Houston Medical School.

Contact: Deborah Mann Lake
deborah.m.lake@uth.tmc.edu
713-500-3304
University of Texas Health Science Center at Houston

Public Release: 28-Oct-2014
Journal of the Royal Society Interface
Global infection outbreaks, unique diseases rising since 1980
Ebola has a lot of company. In a novel database now made publicly available, Brown University researchers found that since 1980 the world has seen an increasing number of infectious disease outbreaks from an increasing number of sources. The good news, however, is that they are affecting a shrinking proportion of the world population.
Brown University

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 27-Oct-2014
Annals of Internal Medicine
Study: Prompt isolation of symptomatic patients is key to eliminating Ebola
Below is information about an article being published in Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 27-Oct-2014
Science
GW researcher adapting breakthrough technologies to combat parasitic worm infections
Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine, and scientific director of the Research Center for Neglected Diseases of Poverty at the George Washington University School of Medicine and Health Sciences, co-authored a perspective in the journal Science, calling for researchers to adapt new technologies to research neglected parasitic flatworms.

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 27-Oct-2014
TWAS 25th General Meeting
Molecular biologist Muntaser Ibrahim wins C.N.R. Rao Prize
Every year, malaria kills about a million people worldwide, 90 percent of them in sub-Saharan Africa. Prize winner Muntaser Ibrahim studies the connection between malaria, human communities and genes.

Contact: Edward Lempinen
elempinen@twas.org
39-040-224-0429
TWAS

Showing releases 201-225 out of 960.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>